<DOC>
	<DOCNO>NCT00861549</DOCNO>
	<brief_summary>The purpose study evaluate bioavailability two formulation ( Taiwan China mainland ) phencynonate hydrochloride tablet generate pharmacokinetic safety profile phencynonate hydrochloride healthy volunteer .</brief_summary>
	<brief_title>Bioavailability , Pharmacokinetics Safety Evaluation Phencynonate Hydrochloride Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Subjects must sign date informed consent form . 2 . Subjects must ≧ 18 ≦ 40 year old , healthy , nonsmoking male . 3 . Subjects body weight within ± 20 % ideal body weight 4 . Subjects urinalysis data within acceptable range , include pH , blood , glucose protein 5 . Subjects laboratory evaluation data within acceptable range , include serum chemistry examination ( glucose , total cholesterol , TG , SGOT , SGPT , GSP , alkaline phosphatase , total bilirubin , total protein , albumin , rGT , BUN , creatinine , uric acid ) hematology ( complete blood count platelet ) 6 . Subjects acceptable ECG chest xray 1 . Subjects take drug within 14 day prior screen . 2 . Subjects history glaucoma 3 . Subjects history ileus 4 . Subjects history benign prostate hypertrophy urine retention 5 . Subjects history myasthenia gravis 6 . Subjects history asthma 7 . Subject history medical condition , opinion investigator , compromise subject safety ability comply study procedures 8 . Subjects history drug alcohol addiction abuse within 1 year prior screen 9 . Subjects hypersensitivity phencynonate hydrochloride drug similar chemical structure 10 . Subjects donate blood 250 mL within pervious 3 month prior study 11 . Subjects receive investigational drug within 1 month prior screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Safety Evaluation</keyword>
</DOC>